Sarah Kenigsberg Selected Research

nucleotide pyrophosphatase

1/2018	Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug.
6/2014	Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah Kenigsberg Research Topics

Disease

2	Chondrocalcinosis (Pseudogout) 01/2018 - 06/2014
2	Osteoarthritis 01/2018 - 06/2014
1	Type 2 Diabetes Mellitus (MODY) 06/2014

Drug/Important Bio-Agent (IBA)

2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018 - 06/2014
2	nucleotide pyrophosphataseIBA 01/2018 - 06/2014
1	Calcium PyrophosphateIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018